Anaesthetic organ toxicity: Is it really a problem?

Current Opinion in Anaesthesiology

Volumn 11, Issue 4, 1998, Pages 399-401

  Nelson, Philip D ^a   Ferguson, Catriona N ^a   Jones, Ronald M ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; HALOTHANE; METHOXYFLURANE; SEVOFLURANE;

DRUG MONITORING; DRUG SAFETY; DRUG WITHDRAWAL; GENOTOXICITY; JAPAN; LIVER TOXICITY; NEPHROTOXICITY; PRIORITY JOURNAL; SHORT SURVEY; UNITED KINGDOM; UNITED STATES;

EID: 0031849890     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-199808000-00004     Document Type: Short Survey

References (14)

1. Reeves M. Acute hepatitis following enflurane anaesthesia. -Anaesth Intensive Care 1997; 25:80-82.
2. Martin JL, Plevak DJ, Flannery KD, Charlton M, Poterucha JJ, Humphreys CE, et al. Hepatoxicity after desflurane anesthesia. Anesthesiology 1995; 83:1125-1129.
3. Tiainen P, Rosenberg PH. Hepatocellular integrity during and after isoflurane and halothane anaesthesia in surgical patients. Br J Anaesth 1996; 77:744-747.
4. Darling JR, Murray JM, McBride DR, Trinick TR, Fee JPH. Serum glutathione S-transferase concentrations and creatinine clearance after sevoflurane anaesthesia. Anaesthesia 1997; 52:121-126.
5. Kharasch ED, Frink EJ, Zager R, Bowdel TA, Artru A, Nogami WM. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. Anesthesiology 1997; 86:1238-1253. This study showed that there is no difference between isoflurane and sevoflurane in terms of clinically significant alterations of renal function after low-flow anaesthesia.
6. Laster MJ, Gong D, Kerschmann RL, Eger El, Martin JL. Acetaminophen predisposes to renal and hepatic injury from compound A in the fasting rat. Anesth Analg 1997; 84:169-172.
7. Eger El, Koblin DD, Bowland T, Ionescu P, Laster MJ, Fang Z, et al. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997; 84:160-168.
8. Njoku D, Laster MJ, Gong DH, Eger El, Reed GF, Martin JL. Biotransformation of halothane, enflurane, isoflurane and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg 1997; 84:173-178.
9. Kharasch ED, Thorning D, Garton K, Hankins DC, Kitty GC. Role of renal cysteine conjugate β-lyase in the mechanism of compound A nephrotoxicity in rats. Anesthesiology 1997; 86:160-171.
10. Iyer RA, Anders MW. Cysteine conjugate β-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria. Anesthesiology 1996; 85:1454-1461.
11. Bito H, Ikeuchi Y, Ikeda K. Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia. Anesthesiology 1997; 86:1231-1237.
12. Kharasch ED, Hankins DC, Thummel KE. Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology 1995; 82:689-699.
13. Eger El, Laster MJ, Winegar R, Han C, Gong D. Compound A induces sister chromatid exchanges in Chinese hamster ovary cells. Anesthesiology 1997; 86:918-922.
14. Mazze RI, Jamison RL. Low-flow (1 l/min) sevoflurane. Is it safe? [Editorial]. Anesthesiology 1997; 86:1225-1227. This editorial is required reading in order that an informed opinion can be made if anticipating using sevoflurane at low fresh gas flow rates.